MedTrace Logo

Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome

NCT06240364 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-05-19

No results posted yet for this study

Summary

Previous research has demonstrated the effectiveness of AFFRONEYE® / CROCUVIS+® dietary supplement, based on saffron extract, in the proper functioning of visual health, for example, against the development of glaucoma. The main objective of this study is to compare the results of clinical tests that evaluate signs and symptoms for the diagnosis of dry eye, between two groups (some that take the dietary supplement and others a placebo), in a sample of university workers and students who suffer from dry eye.

Conditions

  • Dry Eye Syndrome

Interventions

DIETARY_SUPPLEMENT

Saffron extract (Crocus sativus)

Daily intake of one tablet for 84 days.

DIETARY_SUPPLEMENT

Placebo

Daily intake of one tablet for 84 days.

Sponsors & Collaborators

  • Pharmactive Biotech Products S.L.U

    collaborator INDUSTRY

  • University of Alicante

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-10
Primary Completion
2026-04-30
Completion
2026-12-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06240364 on ClinicalTrials.gov